JBC Ideal method for primary cell transfection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M312660200 on January 15, 2004

J. Biol. Chem., Vol. 279, Issue 14, 13375-13382, April 2, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/14/13375    most recent
M312660200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sato, M.
Right arrow Articles by Lanier, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sato, M.
Right arrow Articles by Lanier, S. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

AGS3 and Signal Integration by G{alpha}s- and G{alpha}i-coupled Receptors

AGS3 BLOCKS THE SENSITIZATION OF ADENYLYL CYCLASE FOLLOWING PROLONGED STIMULATION OF A G{alpha}i-COUPLED RECEPTOR BY INFLUENCING PROCESSING OF G{alpha}i*

Motohiko Sato{ddagger}§, Thomas W. Gettys{ddagger}, and Stephen M. Lanier{ddagger}||

From the {ddagger}Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112 and the Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808

AGS3-LONG and AGS3-SHORT contain G-protein regulatory motifs that interact with and stabilize the GDP-bound conformation of G{alpha}i > G{alpha}o. AGS3 and related proteins may influence signal strength or duration as well as the adaptation of the signaling system associated with sustained stimulation. To address these issues, we determined the effect of AGS3 on the integration of stimulatory (G{alpha}s-mediated vasoactive intestinal peptide receptor) and inhibitory (G{alpha}i-mediated {alpha}2-adrenergic receptor ({alpha}2-AR)) signals to adenylyl cyclase in Chinese hamster ovary cells. AGS3-SHORT and AGS3-LONG did not alter the VIP-induced increase in cAMP or the inhibitory effect of {alpha}2-AR activation. System adaptation was addressed by determining the influence of AGS3 on the sensitization of adenylyl cyclase that occurs following prolonged activation of a G{alpha}i-coupled receptor. Incubation of cells with the {alpha}2-AR agonist UK14304 (1 µM) for 18 h resulted in a ~1.8-fold increase in the vasoactive intestinal peptide-induced activation of adenylyl cyclase, and this was associated with a decrease in membrane-associated G{alpha}i3. Both effects were blocked by AGS3-SHORT. AGS3-SHORT also decreased the rate of G{alpha}i3 decay. A mutant AGS3-SHORT incapable of binding G-protein was inactive. These data suggest that AGS3 and perhaps other G-protein regulatory motif-containing proteins increase the stability of G{alpha}i in the membrane, which influences the adaptation of the cell to prolonged activation of G{alpha}i-coupled receptors.


Received for publication, November 19, 2003 , and in revised form, January 12, 2004.

* This work was supported in part by Grants NS24821 and MH55391 from the National Institutes of Health (to S. M. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Supported in part by the Mochida Memorial Foundation for Medical and Pharmaceutical Research.

|| Supported by the David R. Bethune/Lederle Laboratories Professorship in Pharmacology and a Research Scholar Award from Yamanouchi Pharmaceutical Company, Ltd. To whom correspondence should be addressed: Dept. of Pharmacology, Louisiana State University Health Sciences Ctr., 1901 Perdido St., New Orleans, LA 70112. Tel.: 504-568-4740; E-mail: slanie{at}lsuhsc.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. M. Filipeanu, F. Zhou, M. L. Lam, K. E. Kerut, W. C. Claycomb, and G. Wu
Enhancement of the Recycling and Activation of beta-Adrenergic Receptor by Rab4 GTPase in Cardiac Myocytes
J. Biol. Chem., April 21, 2006; 281(16): 11097 - 11103.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Mouledous, J. Neasta, S. Uttenweiler-Joseph, A. Stella, M. Matondo, M. Corbani, B. Monsarrat, and J.-C. Meunier
Long-Term Morphine Treatment Enhances Proteasome-Dependent Degradation of G{beta} in Human Neuroblastoma SH-SY5Y Cells: Correlation with Onset of Adenylate Cyclase Sensitization
Mol. Pharmacol., August 1, 2005; 68(2): 467 - 476.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.